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Abstract 
Objective: This study explores patient’s experience during the first three months 
following a diagnosis of malignant pleural mesothelioma. 
Methods:  This study uses a grounded theory approach with semi-structured, face-to- 
face interviews with ten patients during the first 3 months following diagnosis. 
Results:  The  key concept that emerged from the data was this: Uncertainty and lack 
of control,  leading to emotional, physical and psychosocial distress.  Three themes 
informed the key concept: ‘ it’s all bad news’,  ‘good and bad days’ and strategies of 
amelioration.  Patients worked with a short-term perspective on their illness but 
worried about the long-term outcome and the speed of their deterioration.  
Conclusion:   Patients receive insufficient psychosocial support during the first three 
months following diagnosis.  An early palliative care referral would improve support 
and referral strategies during the first three months of the disease.   
 
Introduction 
Malignant pleural mesothelioma (MPM) is a complex and difficult cancer affecting the 
lining of the lung.  MPM is linked to exposure to asbestos and invariably leads to a 
short life expectancy [1]. However there is reported to be a huge variability in the 
course of the illness with some patients experiencing a slower disease progression 
and others more aggressive disease [2].  MPM is more likely to occur in late middle 
age with a long latency period between exposure to asbestos and the appearance of 
the disease [3].  There can be problems in achieving a diagnosis in the early stages 
and this is because symptoms such as chest pain can be mistaken for cardiac 
disease [4,5]; alongside this are quality of life issues related to emotional distress, 
experience of symptom such as pain and breathlessness and complicated medico-
legal and financial concerns [4,5].   So far treatment has not achieved improvement 
in survival and palliative and supportive care is important to sustaining a good quality 
of life [6,7].   Research on this patient group is limited and care and support is based 
on the needs and care pathways of those with lung cancer,  which may not reflect the 
concerns of those with MPM [8].  With the incidence of MPM rising and expected to 
peak between 2010 and 2015, it is timely to produce research evidence related to the 
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patient’s experience in the early phase of the illness following diagnosis and to 
investigate how patients are supported.  This study is concerned with the patient’s 
experience in the first three months following diagnosis of malignant pleural 
mesothelioma (MPM).  
Literature Review 
Malignant Pleural Mesothelioma is the most common cancer of the pleural cavity and 
80% of mesothelioma’s originate in the pleural space [9]. The typical presentation is 
chest pain  and dyspnoea [4,5].  The pain may involve a heavy feeling in the chest, 
aching in the shoulder and arm, chest wall and upper abdomen.  The disease is 
invariably fatal, although there are exceptions [8 ] with some experiencing periods of 
stability.  However many people die within a year of diagnosis [1].  
The care of people with mesothelioma in Australia has been described as a ‘medical 
lottery’ as patients may not receive the referrals and services they need [7]. Patients 
and carers of those with MPM report many unmet needs with 90% of patients 
reporting pain and breathlessness, cough, appetite loss, fatigue, sleep disturbance 
and sweating [8,9]  most significantly psychosocial distress is reported as a serious 
issue for patients and families [4,5,10].   Sweeney (a medical doctor) describes 
severe emotional distress following his diagnosis of MPM experiencing inadequate 
support from healthcare staff who avoided his distress [11].  The diagnosis is difficult 
for health care practitioners to deliver because of the lack of effective treatments and 
the short prognosis.  
Charmaz (1997) reports the catastrophic loss of control over life experienced by 
those living with the consequences of chronic illness and advanced cancer with the 
loss of self-esteem resulting in a diminished self [11,12].  In studies of patients with 
mesothelioma it is reported that they felt their health was controlled by external 
factors such as luck or powerful others and this resulted in depression, anxiety,  
helplessness and fatalistic attitudes [13,14].  The cultural imperative to think 
positively about cancer may mean that those who have reached a point where this is 
not possible may find themselves alone in confronting their mortality [15,16].   
Charmaz [17] observes how losses “are most marked at the onset of a serious, 
debilitating illness or at points when ill persons define former actions, lives and selves 
as now  precluded by illness” [17].   
In a study of patients with small cell lung cancer it was found that doctors rarely 
discussed the course of the illness with patients [18].  Specialists tended to focus on 
the short-term aspects of illness such as treatment schedules, laboratory tests, 
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investigations and generally did not discuss the longer-term aspects of the illness 
[19,20].  The advantage of focusing on the short-term perspective is that it focuses 
attention on treatment and instils optimism around treatment schedules and avoids 
the poor outcomes.  The short-term perspective provides structure to the illness 
experience and helps the patient (and the staff) with this difficult period by making it 
orderly and manageable [19]. Although there is considerable research into the 
experience of lung cancer, little research has focused on the early phase of the 
illness following diagnosis of MPM and the  short-term and longer-term concerns 
from the patient’s perspective.   
 
 
Aim 
 
To explore patient’s experience during the first 3 months following a diagnosis of 
MPM. 
 
Method 
 
This study used a grounded theory approach [21], where theoretical propositions and 
theories are ‘grounded’ in the reality of the data collected [22]. This approach was 
used to discover what was going on in relation to the participant’s recently diagnosed 
with pleural mesothelioma.  Theoretical sampling was used where data were  
collected, coded and analysed and then decisions were made about where next to 
find data; this process was repeated until data saturation was achieved with ten 
participants and included two women [21,23].  The sampling strategy was affected by 
the difficulty in recruiting patients due to the small numbers of patients on two 
hospital  sites.  Two patients were too ill to be interviewed and it took one year to 
recruit 10 people to the study.  Eventually, ten patients (eight men and two women) 
were recruited from two acute trusts in the South of England (See Table 1 for patient 
characteristics and performance status).  All participants apart from one (John) were 
interviewed in their home, with John being interviewed in the out-patient department 
of the local hospital.  
 
Data were collected by open-ended, audio-recorded  interviews where participants 
were asked open ended questions about their experience leading up to diagnosis, 
receiving the news of their illness and subsequent experiences of treatment, care 
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and coping. One participant (John) did not want the interview audio-recorded but he 
agreed for the researcher to take notes.  Later on in the interviews more closed 
ended questions were asked to clarify points about symptom experience and support 
without distorting the rapport built up with participants by use of open-ended 
questions. The function of interviews in grounded theory is to draw out the 
participant’s story.  For example the researcher started by asking:  ‘When did you 
first notice something was wrong?’  Probing questions were used to encourage the 
participants to tell their story of their experience and to ensure that the researcher 
fully understood the meaning of what was being said as well as the context. During 
the first interview the issue of uncertainty was raised: ‘It’s just the uncertainty really’. 
This became an important theoretical construct and the work of Charmaz [12] related 
to chronic illness was used to explore and develop this concept further [12].  Using 
the constant comparative method the issues of uncertainty and ‘bad news’ were  
found to be relevant in all subsequent interviews.  The constant comparative method 
was used for analysis of the transcribed data with text coded and compared for 
similarities and differences until substantive categories and themes emerged. The 
interview transcripts were coded line by line and key words such as ‘uncertainty’ ‘bad 
news’ were highlighted.  Initial patterns began to emerge from the first interview, and 
this informed further interviews. The key words and phases were highlighted on the 
transcript,  categories were formed that supported the key concept of uncertainty and 
loss of control. Emerging codes were compared to existing codes, to examine 
similarities or differences. As data analysis progressed, relationships between the 
categories and subcategories were developed through axial coding [24].  Analysis 
continued until each category was refined and saturated and no new properties 
emerged [24].  The research proposal was approved by the National Research Ethics 
Service, the Hospital Trust’s Research and Development Committee and the 
University Ethics Committee.  Recruitment to the study took place during 2008-2009 
and one researcher carried out all the interviews.  
 
Findings 
 
The  key concept that emerged from the data was: uncertainty and lack of control, 
which  lead to emotional, physical and psychosocial distress during the first three 
months following diagnosis.  Three themes informed the key concept: ‘ it’s all bad 
news’,  ‘good days and bad days’ and strategies of amelioration.   
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Uncertainty and lack of control 
 
All participants report high levels of uncertainty and feelings of a lack of control 
leading to psychosocial distress since receiving their diagnosis.  In mesothelioma 
unpredictability is linked to uncertain disease trajectory and the poor prognosis [3].  
Participants describe the shock of receiving the diagnosis and the uncertainties 
related to how the disease will progress and the timescale involved in their physical 
decline.   
 
Ivan was preparing for the worst case scenario thinking that he was going to die very 
soon.  He was planning and preparing for his death and his funeral. Ivan goes on to 
talk about his uncertainties and struggles in relation to his life expectancy:  
I don’t know what tomorrow will bring, or next month, I don’t even know if I 
can look to Christmas….really, I don’t know the speed of these things or…but 
I just don’t know. Something might turn up, who knows. 
Ivan reports great anxieties around the speed of his disease progression and how 
long he can expect to live. He uses ‘I don’t know’ four times in this data extract 
emphasising his loss of certainty in the future whether that is tomorrow or at another 
date in the future.  In particular he is worried about the speed of his decline and what 
is going to happen to him.   He can only think that something might turn up.  He is in 
despair about the loss of certainty in his life and there is a felling that nobody can 
help him with this as ‘who knows’.  There is a feeling from Ivan  that no one is in 
control of this situation.  
 
Uncertainty in cancer has been called the ‘Damocles Syndrome’ not knowing when 
the tragedy will occur but knowing it is unavoidable leads to distress and suffering 
[25].  Uncertainty is most acute during the early stages of illness following diagnosis 
[26].  Participants also face worries about the treatment schedule, Henry, describes 
the uncertainties he faces in the medical system.  He describes how he has been  in 
‘limbo’ following his radiotherapy: 
 
I had a session at [Cancer Centre].  There is no liaison.  I finished me 
radiotherapy but then I was left in limbo…There doesn’t seem to be a link with 
the patient… I mean I got home and I thought well what happens now,   you 
know. 
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Henry is confused about what is going to happen next in the treatment trajectory.  He 
lacks information and understanding about the next step in the treatment trajectory 
leading to feelings of  uncertainty and distress around ‘what happens now’.   
  
John describes concerns and worries for his wife who washed his clothes, which 
were covered in asbestos when he was working for a heating company:   
 
Hoping it is not going to contaminate my wife she washed my clothes when  I 
was working for the heating company and I had asbestos all over them. 
 
John uses the word ‘contaminate’ in this sense his wife is also in danger and  
potentially ‘contaminated’ because of the asbestos being transferred from his clothes 
to his home.   John came across as very angry and anxious during the interview.  He 
was the only participant to request the interview to be held outside of the home and 
did not want it to be audio-recorded; however he agreed to the researcher taking 
written notes. 
John is also are working closely with solicitors who visit him at home.  He is awaiting 
the outcome of investigations in relation to the possibility of making a claim against 
two previous employers regarding his contact with asbestos during his work as a 
heating engineer: 
 
The only thing I’m waiting for is the solicitor following those two companies, 
which are no longer trading.  I have to wait and see and not sure of the 
outcome. 
 
The feelings of distress and despair communicated during all the interviews were 
related to loss of control not only of the body but of one’s life.  The speed at which 
things were happening led to  an incomprehension about what was going to happen 
next and support the findings of Charmaz [12] around the loss of control over life [12].  
The language of distress and uncertainty used by participants were communicated 
using words such as:  ‘not sure’, ‘I’m waiting’, ‘contaminate’ , ‘left in limbo’, ‘what 
happens now?’, ‘I don’t know’, ‘who knows’.  These words reflect the loss of control 
and insecurity about how to live and who can possibly help. 
 
The following sub themes support the main themes and are the components of 
uncertainty, and loss of control of life leading to distress but tempered by strategies 
of amelioration.   
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 ‘It’s all bad news’ 
All the participants found it difficult to cope with their diagnosis due to all the negative 
information and ‘bad news’ around MPM and this led to feelings of depair.  
Henry says:   it’s all bad news isn’t it? 
By this question there is an expectation that the interviewer also shares the 
perspective on the bad news of having mesothelioma.  
Chris while acknowledging the bad news doesn’t want to think about or dwell on the 
future therefore he prefers to bury his head in the sand:  
It doesn’t pay to think too far down the road because that’s bad news.   As 
you say, head in the sand. 
The metaphor of ‘head in the sand’ is one way to deal with a devastating prognosis 
and this was a mechanism of keeping the bad news at bay for now.  This helped 
Chris to avoid the realisation of the ‘bad news’ and what the future holds by avoiding 
thinking about it.  Denial has been found to be a common psychological response in 
those with mesothelioma and industrially acquired lung disease [13,14]. 
Doug also feels that all the information he has received is negative:  
…negative information around having such a disease. 
The feeling of negativity around the diagnosis is difficult for participants to come to 
terms with and it immediately fills people with dread about the future and what the 
illness means.  
The poor prognosis related to MPM causes a dilemma in relation to whether to 
continue treatment given  the poor outlook presented by medical staff as well as the 
negative information in patient information booklets and on the Internet. For example 
Anita, who had been investigated for around 12 months for a cardiac illness before 
being diagnosed described  how she started a course of chemotherapy but felt that it 
was compromising her quality of life due to all the side effects she was having:  
I’ve just been on the Internet site for meso and ahm in the book that I had 
they gave me on it,  it said there wasn’t much point in having chemotherapy 
you know it ahm.  So when I was so ill after that first session I was really ill I 
just couldn’t face going having it all done again. 
Anita took the decision to discontinue chemotherapy treatment and then sought a 
referral to the palliative care team.  The negative attitude to the disease appears to 
be communicated to patients in a number of ways both in the written material offered 
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to patients in information booklets, in the verbal and non-verbal behaviour of staff [11] 
and from material on the Internet.  Clayson’s study participants also report being 
given a hopeless message by medical staff who were reported to have said :  ‘I can’t 
give you much hope’,  and another,  ‘we don’t think we can help you’; and another,  
‘she said it’s mesothelioma, it’s malignant, it’s terminal and there’s no treatment’ [4].    
 ‘Good days and bad days’ 
Uncertainties about daily living in serious illness when good and bad days occur 
restricts peoples’ lives [11].  Leading a restricted life means avoidance of physical 
activity, and reduced social contacts,  which protects the person but at a cost to their 
self-image.   
 
 Doug describes ‘good days and bad days’: 
 
…good days and bad days’ and ‘ if I have a late night I’m affected the 
following day”. 
 
Participants experienced tiredness and fatigue which is a common problem in MPM 
[9].  None of the participants were breathless at rest, during the interview but 
described some breathlessness on exertion.  Breathlessness for many participants  
improved following medical pleurodesis to treat pleural effusion.  
Those that reported pain describe mild pain such as an ache, tenderness or 
soreness in the chest.  John describes a little ache: 
I’ve noticed a little ache in the chest (rubbing his chest) but doesn’t affect me   
sleeping 
Anita has an ache in her side that is tender and felt a pressure in her chest:  
It feels as though there is just something pressing down on you all the time.   
Gill describes pain that is not controlled with Paracetamol.   She has now been 
prescribed Tramadol to help with her pain: 
The centre of the chest is painful but it’s only sore to touch, but I do get pain 
but the pain is mostly at night, I think during the day, because you, you are 
talking and you are pottering about, you take no notice, it isn’t pain that’s 
there continually. 
Patients are experiencing pain but not necessarily reporting it to hospital staff.  Gill 
needed stronger analgesics for her pain and there was a delay in getting Tramadol. 
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The fact that pain was not reported as a major problem early on in the disease is 
found in other studies [4].  However patients did describe aches, soreness and 
tenderness around the chest but were more likely to describe discomfort rather than 
pain which was managed by analgesics. 
Participant’s report feeling distressed when experiencing sweating particularly at 
night: 
 Doug:  And the other thing too that I’ve noticed and it’s causing arguments      
between us, is that it’s almost like what I imagine the female menopause to 
be.  I’m sweating and I’m hot. 
Interviewer: Is that any time or at night? 
Doug: No it’s, if it gets warm or the heating’s on or I’m, we went shopping to  
a big shop, Macros, last week with two friends, and I had to go out and sit in 
the car.  They were laughing at me because I’d taken me coat off and they 
said they were cold, but I was sort of sweating, until I got outside, got in the 
colder air, sat in the car, opened all the windows and I was all right, just sitting 
there and it had gone. 
 
 Sweating is a difficult problem for  Doug as his friends are laughing at him and his 
wife is also finding it difficult to cope with.  Henry also reports night sweats that he 
describes as ‘horrible’ and this disturbs his sleep: 
Henry:   Yeah the sweating yeah… 
Interviewer::    and is that every night or? 
Henry:   Three times a night I have to change. 
 
The day and night sweats caused a lot of distress to patients.  In particular it 
disturbed sleep at night and the feeling of coldness was also a persistent problem for 
some people.  In a case note review of 80 patients with mesothelioma, sweating was 
reported in 14 (18%) of the case notes studied [4].  In the present study half of the 
participants experienced sweating.  
 
Strategies of amelioration:  
Participants did find positive events that helped them cope with the illness.  Charmaz 
[12] calls finding positive events as a turning point because it ‘demonstrates 
resiliency of self’ and it presents the individual as having taken control of the illness 
rather than the illness taking control of the person [12].   Participants describe a 
number of strategies to help them cope such as use of complimentary and alternative 
medicine (CAM), visits from the Asbestos Support and Awareness Group (ASAG), 
and referral to palliative care.   
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Ivan is using CAM involving a special diet and this provided Ivan with a feeling of 
control and that he could do something  positive to help himself and helped him cope 
with  the many uncertainties around his illness.   
Many of the patients on one of the study sites received excellent support from the 
Asbestos Support Group (ASAG) within their locality:  
 
 I‘ve had help from ASAG, wonderful people… She filled in the forms for the 
disability. I haven’t had to do anything (John) 
 
Participants had received home visits from legal representatives and from members 
of ASAG, which is a charity providing advice and support for those affected by 
asbestos related diseases.   All the participants felt well informed about the legal 
aspects related to this condition and how to claim compensation.   
 
Anita describes not wanting to hear about making claims for compensation during the 
bad news consultation. She felt that claiming was the last thing on her mind following 
the shock of her diagnosis: 
  
  Anita:   But that was the last thing on my mind.  I can’t be bothered to 
go through claiming you know it was such a shock ahm. 
Interviewer:   Of course. 
Anita:   So ahm I don’t think that was such a good idea to say it so 
early on in a way. 
Interviewer:   It might be better for that to come later 
Anita:   Just to leave it a bit so you get over your diagnosis and get 
settled down a bit and then may be say you can apply for 
compensation. 
Interviewer:   Because everything is so overwhelming. 
Anita:    It is yes it is such a shock really yeah. 
 
The issue about the timing of information related to claiming compensation is found 
found in other studies [4].  The best time to introduce information about financial 
claims is not clear and raising the issue at diagnosis can be a distraction from the 
emotionally charged news of an incurable disease.   
Few of the participants had received a palliative care referral.  Anita had asked for a 
palliative care referral, she had recently received a home visit from the palliative care 
nurse which she found very helpful and was now referred to a hospice 
breathlessness clinic.  Gill had also been referred to palliative care but had yet to 
receive a home visit. None of the other participants report a palliative care referral.   
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Discussion 
The participants in this study struggled to come to terms with their illness during this 
early phase and experienced the shattering of their hopes and dreams for the future. 
Uncertainty, has been found to be related to emotional distress and with lower levels 
of satisfaction with life [27]. Psychosocial distress is reported as a serious issue for 
patients and families living with mesothelioma [4,10,11]. Participants in this study 
describe their own short-term perspective on coping with the illness such as burying 
one’s head in the sand, denial and avoiding negative information. This enables some 
participants to keep some control of the situation and helps with coping in the early 
stage of the illness. However the longer term perspective was on the participants’ 
mind and they were worried and anxious about how they would physically deteriorate 
and when this would happen.   
In a study of patients with small cell lung cancer [18] it was noted how patients use 
narratives of restitution and optimism about their illness and treatment early on in the 
illness.  Regarding the patients in the present study narratives of restitution were 
largely absent.   Restitution narratives were unavailable to participants because 
everything they hear and read about the disease is so negative.  All the ‘bad news’ 
around the illness compounded by the reported non-verbal and verbal 
communication from health professionals can’t sustain narratives of restitution [4,11].   
Frank [28] describes illness as a loss of predictability of the functions of the body and 
involves learning to live with a loss of control [28].  There is evidence in this study of 
a significant symptom burden alongside the psychosocial distress caused by living 
with uncertainty.  Coupled with breathlessness on exertion is the feeling of fatigue 
and tiredness which further restricts participants physical capacity.  Some patients 
coped well with physical restrictions and others struggled to adapt their lifestyle and 
pace their activities.  Some people adapt to the situation involving chronic illness 
more easily while for others there is a ‘crisis of control’ [28].  Many participants in the 
present study suffered from day/night sweats, which caused immense distress.  This 
symptom is not included in quality of life questionnaires for studying mesothelioma 
[4].  Therefore the frequency of this symptom is probably underestimated in many 
studies.  At this early stage in the illness participants did not describe suffering from 
intractable pain. Symptoms and emotional suffering are linked because personal 
identity is shaped through the body [28].  Failure  to control the body in relation to the 
experience of symptoms causes uncertainty and a sense of unpredictability [29].   
Interventions that focus on helping patients to manage the physical and psychosocial 
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aspects of their condition during the first three months will improve patient’s quality of 
life and personal efficacy and lead to a reduction in emotional distress.  
 
The uncertainty and lack of control experienced by participants extended to having 
difficulty understanding who was in charge of their care when they moved across 
hospitals for investigations and treatment. Chaos feeds on the sense that no one is in 
control [28].   Problems are reported when patients are under the care of several 
hospitals so that some were bewildered by the number of doctors involved in their 
care and could not determine who was in overall charge. This lack of continuity with 
medical staff results in high levels of uncertainty [27]. Participants in the present 
study did not have any insight into the multidisciplinary nature of the caring team and 
some participants were unsure of the next step in the treatment trajectory which 
engendered feelings of insecurity and led to a lack of control and ability to plan. 
 
Clinicians delivering the diagnosis of MPM need to carefully consider the best and 
most sensitive way to deliver the ‘bad news’  and the timing of information about 
claims for compensation.  There is evidence that this should not come in the 
diagnostic consultation.  Few patients had a palliative care referral and the reason for 
this is unclear.  Wide variations in palliative care referrals are reported in other 
studies leading to inadequate symptom relief and emotional care [7].   
 
Patients need the opportunity of a home visit with a specialist nurse/palliative care 
practitioner soon after the diagnosis and this should occur within the first three 
months of the disease.  This visit should enable the patient to tell their story of this 
illness often characterised by contact with asbestos and enable the proactive 
assessment and management of psychosocial distress and symptoms [30]. Patients 
should be given the opportunity to voice their worries and concerns particularly about 
the risk of passing the disease on to family members and a plan should be put in 
place for management and referral strategies for specialist psychosocial support 
should it be deemed necessary in the short and longer-term.   
Conclusion 
The results of this study identify the emotional turmoil experienced by patients during 
the first three months of the illness.  Uncertainty and loss of control were key features 
of the patient experience causing immense distress.  Uncertainty around how they 
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would decline led some patients to avoid information and bad news, by burying their 
head in the sand.  Palliative care referrals were unusual during the first 3 months of 
the disease. This situation seems to relate to the short-term perspective taken by the 
health care professionals during the first three months of the illness.   Patients had to 
find their own strategies and resources to cope with the illness at this early stage.  
Limitations of the study 
This study is limited by a small sample size and participants were living in an affluent 
part of the UK who were interviewed during the first three months following diagnosis.  
Therefore the findings of this study may not be generalisable to the experience of 
patients in other phases of the illness trajectory and in other parts of the UK.  
 
Funding: Surrey, West Sussex and Hampshire Cancer Network generously funded 
this study.  I have no financial relationship with the organisation that funded the 
study.  
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